Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences

Organization
NCI
Type
NIH NOSI
Application Due Date
05-08-2029
Number
NOT-CA-24-022
Brief Description

Purpose

This Notice of Special Interest (NOSI) from the National Cancer Institute (NCI) invites applications from early career scientists conducting research within the mission of the Division of Cancer Control and Population Sciences for the Mentored Research Scientist Development Award (K01).

Background

The mission of NCI's Division of Cancer Control and Population Sciences (DCCPS) is to advance research in cancer control and population sciences to eliminate cancer and its consequences for all.

Cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. DCCPS has several broad areas of interest: development and validation of methods, technologies, and tools in surveillance, statistics, epidemiology, health care delivery, and the behavioral sciences; identification of modifiable risk factors or host susceptibility factors associated with cancer etiology, cancer prevention, and treatment outcomes; and clinical and translational science to reduce risk, incidence, and death from cancer, as well as enhance the quality of life for cancer survivors. DCCPS also has an interest in cross-cutting themes, health disparities and health equity , implementation science , and cancer survivorship .

To this end, the NCI Cancer Training Branch in the Center for Cancer Training and DCCPS are issuing this announcement to allow applications from early-career scientists conducting research within the mission of DCCPS to the K01 Mentored Career Development Award funding opportunities.